#What is Benchmark's new strategy in venture capital?
Benchmark, known for its small funds and significant investment decisions, has taken an unusual step by raising about $2 billion through two new funds. This marks nearly a doubling of the usual fund size the firm has historically managed and introduces a growth-stage fund for the first time.
The capital raised includes a $750 million traditional early-stage fund and a $1.25 billion growth fund focused on established startups. Given that Benchmark's prior funds averaged around $425 million, this change signifies a substantial shift in strategy and philosophy.
#Why is Benchmark altering its traditional model?
For decades, Benchmark has been recognized for its specific approach: small funds, equal partnerships, and early-stage investments. Their portfolio boasts giants such as eBay, Twitter, and Uber, but recent experiences, particularly its involvement with Cerebras, an AI chipmaker, have prompted a shift. Benchmark's investment in Cerebras yielded impressive returns after the company went public, highlighting the potential of staying engaged in later funding rounds.
The introduction of the growth fund is a strategic move. Rather than diversifying capital across many startups, Benchmark plans to make a small number of concentrated, high-stakes investments. This method contrasts sharply with their previous operational style, focusing on fewer but potentially more lucrative opportunities.
#How does this impact the venture capital landscape?
Benchmark's shift is significant as it has long been a staunch proponent of the small-fund model, especially during periods when other firms were increasing their fund sizes dramatically. With this dual-fund structure, Benchmark could attract a new class of limited partners, such as institutional investors and pension funds, who may prefer the relatively lower risks associated with growth-stage investing. This shift allows investors who want exposure to start-ups with the stability of more established companies to engage meaningfully with both segments.
#What does this mean for investors and startup founders?
The Cerebras case exemplifies how remaining invested through critical phases like an IPO can yield returns comparable to or exceeding those from early-stage investments. However, this growth fund approach also indicates that Benchmark will not compete for every funding round, potentially controlling valuations for the companies it aligns with.
Growth investments differ greatly from early-stage ones. They often come with higher entry prices and slimmer margins for errors, demanding precise timing on liquidity events. Additionally, the $1.25 billion growth fund brings a level of concentration risk that Benchmark has avoided in the past. If one or two high-conviction investments falter, the losses might be larger than anything previously experienced with their smaller early-stage allocations. This adjusted strategy could redefine how Benchmark engages with both founders and investors in the evolving venture capital ecosystem.